Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Carson Revitalizing Dermablend Brand Following Decision To Retain Business

This article was originally published in The Rose Sheet

Executive Summary

Carson Products will support its Dermablend corrective cosmetics brand with an advertising campaign slated to break in September. The company will then back the brand with a "much larger" push in January 2000, Dermablend CEO Tim Hogan said.

You may also be interested in...



Dermablend

Puerto Rico sales exceeded $30,000 following the brand's June debut in the country, a rate that tracks above the domestic average per door, Carson reports. Dermablend is available in eight Sears and two J.C. Penney doors in Puerto Rico, with a Macy's launch possible for spring 2001. The Puerto Rican entry was backed by a $50,000 advertising and public relations campaign heavily supported by Sears, Carson says. While the entire corrective cosmetics line is available in Puerto Rico, the shades were modified for the local market, the company notes. Carson also plans to move the brand into Brazil and Argentina (1"The Rose Sheet" June 14, 1999, p. 6)

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006768

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel